How MJFF “De-Risks” PD Drug Development Pipeline

The Michael J. Fox Foundation Parkinson's Podcast

One key pillar of The Michael J. Fox Foundation’s research strategy is a focus on “de-risking" potential treatments for Parkinson’s disease. This episode of our award-winning “Parkinson’s Science POV” series explains how lowering the risk associated with developing new therapies leads to a more robust pipeline of treatments. The episode details several recent successes of the strategy.

Like our podcasts? Please consider leaving a rating or review and sharing the series with your network. https://apple.co/3p02Jw0

Join a study today to help speed progress toward better treatments and a cure for Parkinson’s disease. To search for studies in your area, visit Fox Trial Finder at foxtrialfinder.org.

Whether you have Parkinson’s or not, you can help move research forward. Join the study that’s changing everything. Find out more at michaeljfox.org/podcast-ppmi.

Mentioned in this episode:

In 2024 alone, The Michael J. Fox Foundation awarded 195 research grants aimed at medication, mobility, medical devices and more to scientists around the world, all in pursuit of better treatments and closing in on a cure. Your support can accelerate this urgent research. Donate by visiting michaeljfox.org/weneedyou.